The role of immune checkpoint inhibitors (ICI) in the treatment of metastatic non-small cell lung carcinoma in the elderly

被引：2
|
作者：
Chan, Johan [1 ]
Kanesvaran, Ravindran [1 ]
机构：
[1] Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
DECISION-MAKING; POOLED ANALYSIS; OPEN-LABEL; DOCETAXEL; PEMBROLIZUMAB; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; NIVOLUMAB; AGE;
D O I：
10.21037/atm.2019.12.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: The regulatory journey in Brazil
    da Veiga, Cassia Rita Pereira
    da Veiga, Claudimar Pereira
    Machado, Erika
    Drummond-Lage, Ana Paula
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 192
  • [32] Current status of immune-checkpoint inhibitors in the first-line treatment of metastatic non-small cell lung cancer
    Tanaka, Kentaro
    ANNALS OF ONCOLOGY, 2019, 30 : 32 - 32
  • [33] A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer
    Pacheco, Jose M.
    Camidge, D. Ross
    Doebele, Robert C.
    Schenk, Erin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [34] Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
    Altaf, Reem
    Jadoon, Sarmad Sheraz
    Muhammad, Syed Aun
    Ilyas, Umair
    Duan, Yongtao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Qiu, Zhenbin
    Chen, Zihao
    Zhang, Chao
    Zhong, Wenzhao
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [36] Immune Checkpoint Inhibitors in Oncogenic Driven Non-small Cell Lung Cancer
    Fonseca, A.
    Silva, E.
    Coutinho, D.
    Campainha, S.
    Dias, M.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S339 - S340
  • [37] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Soh, Junichi
    Hamada, Akira
    Fujino, Toshio
    Mitsudomi, Tetsuya
    CANCERS, 2021, 13 (16)
  • [38] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [39] Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Jung, Chi Young
    Antonia, Scott J.
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (01) : 29 - 41
  • [40] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
12345